Skip to content

Field Usability Study of Eclipse Mask

Field Usability Study of Eclipse CPAP Device

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05559047
Enrollment
70
Registered
2022-09-29
Start date
2022-11-10
Completion date
2023-01-25
Last updated
2025-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Brief summary

The study is designed to assess the usability of a novel CPAP human interface compared to a traditional nasal mask. Human subjects will interact with two different CPAP interfaces including a traditional CPAP mask and the 2nd generation DreamPort-Eclipse. Subjects will be requested to put on each of the different CPAP interface options a total of three times for a total of 6 trials. The order of device will be randomized.

Interventions

DEVICEEclipse mask

Users will interact with the Eclipse CPAP machine and report on usability/likeability.

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
Bleep, LLC
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

•Male or female ≥18 years old who are impacted by obstructive sleep apnea and currently are familiar with a CPAP device.

Exclusion criteria

* Diagnosis of any medical or behavioral conditions that would compromise subject safety. * Under the age of 18: target for this current version of the platform is the adult population.

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants Who Asked for Additional InformationThroughout the duration of the study (48 hours)The total count of participants who asked for additional information during the course of home use of the mask was recorded
Mask LikeabilityAt 48 hoursA 16-item patient survey was administered to the participants at the end of the study. Patients had to answer according to a Likert scale (1: worst, 5:best). Here, this reflects the average of all the answered items. For example, question number one had an average score of 4.52, question number 2 had an average score of 4.21, etc. Since all questions reflect mask likability, they were averaged to provide an overall score.
Number of Participants Who Experienced Technical IssuesThe duration of the trial (48 h)Total count of participants who reported technical issues during the course of the 48 h home use of the mask were recorded

Countries

United States

Participant flow

Recruitment details

In this study, seventy adherent CPAP users volunteered to trial the Eclipse mask for two nights in their homes. Participants attended an appointment at one of three offices of Sleep Centers of Middle Tennessee (SCMT) and were trained how to use the Eclipse mask, then asked to use the Eclipse for two consecutive nights and then complete a participant survey after the second night. No control group was used. Volunteers were gathered from the pool of SCMT participants.

Participants by arm

ArmCount
Eclipse Mask (Single Arm Study)
Seventy adherent CPAP users will volunteer to trial the Eclipse mask for two nights in their homes. Participants who attend an appointment at one of three offices of Sleep Centers of Middle Tennessee (SCMT) and will be trained on how to use the Eclipse mask, then asked to use the Eclipse for two consecutive nights and then complete a participant survey after the second night. Eclipse novel CPAP mask: Participants will follow instructions to set up and put on the Eclipse nasal mask. The Eclipse removes the headgear associated with traditional CPAP masks, offering a small compact design weighing less than an ounce. The Eclipse uses small and lightweight adhesive seals around the nostrils to create an ergonomic design which accommodates the shape of each individual user. It completes a perfect circuit for CPAP therapy to deliver pressure to the airway and stabilize the user's disordered breathing during sleep (apnea and snoring). Participants will follow instructions to set up and put on the mask. They will fill out a survey about the ease and comfort of putting on and wearing the mask, briefly.
70
Total70

Baseline characteristics

CharacteristicEclipse Mask (Single Arm Study)
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
2 Participants
Age, Categorical
Between 18 and 65 years
68 Participants
Race/Ethnicity, Customized
Asian
7 participants
Race/Ethnicity, Customized
Black
26 participants
Race/Ethnicity, Customized
Hispanic
14 participants
Race/Ethnicity, Customized
White
23 participants
Sex: Female, Male
Female
26 Participants
Sex: Female, Male
Male
44 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 70
other
Total, other adverse events
0 / 70
serious
Total, serious adverse events
0 / 70

Outcome results

Primary

Mask Likeability

A 16-item patient survey was administered to the participants at the end of the study. Patients had to answer according to a Likert scale (1: worst, 5:best). Here, this reflects the average of all the answered items. For example, question number one had an average score of 4.52, question number 2 had an average score of 4.21, etc. Since all questions reflect mask likability, they were averaged to provide an overall score.

Time frame: At 48 hours

ArmMeasureValue (MEAN)Dispersion
Eclipse Novel CPAP MaskMask Likeability4.1 scoreStandard Deviation 0.4
Primary

Number of Participants Who Asked for Additional Information

The total count of participants who asked for additional information during the course of home use of the mask was recorded

Time frame: Throughout the duration of the study (48 hours)

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Eclipse Novel CPAP MaskNumber of Participants Who Asked for Additional Information6 Participants
Primary

Number of Participants Who Experienced Technical Issues

Total count of participants who reported technical issues during the course of the 48 h home use of the mask were recorded

Time frame: The duration of the trial (48 h)

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Eclipse Novel CPAP MaskNumber of Participants Who Experienced Technical Issues7 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026